Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical relevance of antimicrobial resistance testing in chronic wound antiseptic treatment
2018-003321-29Phase 3Terminated
- Sponsor
- RWTH Aachen University
- Start
- Jul 2019
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of Serasept, octenidine and polihexanide in decubitus ulcer, Chronic wound, acute wound and 1 more, sponsored by RWTH Aachen University. Primary endpoint: Reduction of bacteria. Started Jul 2019; status: terminated.
02
Drugs
Seraseptoctenidinepolihexanide
03
Conditions
decubitus ulcerChronic woundacute woundWound infection (WI)
Beyond the preview
Go deeper on 2018-003321-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003321-29.